x
Filter:
Filters applied
- Particle Therapy
Publication Date
Please choose a date range between 2019 and 2020.
Particle Therapy
Particle Therapy With the advent of several proton facilities within Europe and globally, the role of the Radiation Therapist (RTT) will change substantially with respect to positioning and immobilisation, motion management, treatment verification and treatment delivery.
This special issue of tipsRO will collate all of the accepted contributions for publication on particle therapy into one issue so that our RTT readership can easily find papers that discuss common issues that arise in the clinic during their practice.
4 Results
- Virtual Special Section on: Particle Therapy; Edited by Sharon Wong and Ingrid KristensenResearch articleOpen Access
Pro-con of proton: Dosimetric advantages of intensity-modulation over passive scatter for thoracic malignancies
Technical Innovations and Patient Support in Radiation OncologyVol. 15p37Published in issue: September, 2020- Ang Wei Jie
- Laure Marignol
Cited in Scopus: 3Photon-based Radiation Therapy (RT) is used as a surgical alternative for early stage NSCLC and is the mainstay of treatment for locally advanced NSCLC [1]. Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide [2]. This number is expected to double to 3 million deaths by 2035 [3]. - Virtual Special Section on: Particle Therapy; Edited by Sharon Wong and Ingrid KristensenResearch articleOpen Access
Pencil beam scanning proton therapy of Hodgkin’s lymphoma in deep inspiration breath-hold: A case series report
Technical Innovations and Patient Support in Radiation OncologyVol. 13p6Published online: December 21, 2019- Karin M. Andersson
- Anneli Edvardsson
- Annika Hall
- Marika Enmark
- Ingrid Kristensen
Cited in Scopus: 5In Sweden approximately 200 persons are diagnosed with Hodgkin’s lymphoma each year. The majority are adolescents or young adults, but the disease is also present in children and older persons [1]. Since most of the patients are young and the prognosis is very favourable, it is of high importance to minimize the long-term effects of the treatment [2]. - Particle Theory PaperReview articleOpen Access
Proton therapy- the modality of choice for future radiation therapy management of Prostate Cancer?
Technical Innovations and Patient Support in Radiation OncologyVol. 11p1Published online: October 11, 2019- Sophie Mangan
- Michelle Leech
Cited in Scopus: 2Over the last decade, the clinical application of Proton Therapy (PR) for Prostate Cancer (Pca) patients has grown rapidly. However, much controversy still remains as to whether its improved dosimetry translates to clinically meaningful reductions in toxicities compared to Photon Therapy (PT). Similarly, controversy surrounds the robustness of PR plans as well as the cost‐benefit of PR for Pca patients. - EditorialEditorialOpen Access
RTTs-time to prepare for the advent of proton therapy
Technical Innovations and Patient Support in Radiation OncologyVol. 11p26Published online: November 8, 2019- Sharon Wong
- Ingrid Kristensan
Cited in Scopus: 0Proton therapy (PBT) is a technology for delivering conformal beam radiation with positively charged atomic particles to a well-defined treatment volume. The physical characteristics of the charged particles (Bragg peak) allow sparing of much more normal tissue than is possible using conventional X- rays and for this reason, protons are increasingly used all over the world for the treatment of cancers.